Subscribe
Logo small
Search

Children's Ombudsman and Patient Ombudsman appeal to drug manufacturer for reimbursement

MedExpress Team

medexpress.pl

Published March 14, 2024 08:07

Children's Ombudsman and Patient Ombudsman appeal to drug manufacturer for reimbursement - Header image

Achondroplasia is a rare genetic disease manifested, among other things, by short stature. About 560 children in Poland struggle with it. The Children's Ombudsman and the Patient Ombudsman have made a joint request to the manufacturer of the drug, which is intended for children affected by achondroplasia, to apply for reimbursement.

- We aim to ensure that every child, regardless of age, gender, nationality or stage of illness, has real access to me...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie już za 4 zł dziennie*.

* 4 zł netto dziennie. Minimalny okres ekspozycji ogłoszenia to 30 dni.

Read also